Guest guest Posted January 15, 2004 Report Share Posted January 15, 2004 BARRIER Therapeutics Reports Results From Phase III Seborrheic ... News (press release) .... Barrier's current clinical pipeline includes four products in, or entering, Phase III clinical trials to treat fungal infections, Candida- associated diaper ... <http://biz./prnews/040112/nym044_1.html> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.